Device Trial Radar · NCT02545569
Evaluation of New Custom Made Hearing Product Technology and Shell Modification
Last checked: Nov 19, 2026Latest source record: Aug 30, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
25
Planned (sponsor's estimate)
Start
Jan 6, 2020
Primary completion
Dec 2020
Study completion Dec 2020
Sponsor
- Lead sponsor
- Phonak AG, SwitzerlandNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 10, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (participant)
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this evaluation is to receive the greatest benefit of new custom made hearing product technology and shell modification for the end customer and to continual improve the custom made hearing products.
Conditions
- Hearing Loss, Bilateral or Unilateral
Interventions
hearing aid (MD class IIa) - ITE, BTE, RICDevice
Hearing aid means any wearable instrument or device designed for, offered for the purpose of, or represented as aiding persons with or compensating for, impaired hearing.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective measurement of speech intelligibility related to the intervention.Time frame: 5 years
- Objective measurement of the transfer function related to the intervention.Time frame: 5 years
- Objective measurement from the position of the outer ear related to the test subject.Time frame: 5 years
3 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sonova AG
Stäfa, Canton of Zurich, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.